ARTG 462691Severe acute respiratory syndrome-associated coronavirus IVDs
ARTG ID: 462691 · Touch Biotechnology Pty Ltd · Vitrosens Biyoteknoloji LTD STI · Class IIb · Started September 24, 2024
Good Name: Touch Biotechnology Pty Ltd - Severe acute respiratory syndrome-associated coronavirus IVDs
- Risk Class
- Class IIb
- Product Type
- IVD
- ARTG Category
- IVD
- ARTG ID
- 462691
- Start Date
- September 24, 2024
- Effective Date
- September 24, 2024
- Country
- Turkey
- Address
- Serifali Mah Sht Sk No 17/1, Umraniye, Istanbul
Intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19 from symptomatic individuals for self-testing by lay persons (nasal swab).
Access comprehensive regulatory information for Severe acute respiratory syndrome-associated coronavirus IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 462691 and sponsored by Touch Biotechnology Pty Ltd, manufactured by Vitrosens Biyoteknoloji LTD STI in Turkey. The device registration started on September 24, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.